Pellkofer 1989.
Methods | Parallel‐group study lasting up to 35 days | |
Participants | 47 MS patients with disabling lower limb spasticity | |
Interventions | Tetrazepam v. tizanidine v. baclofen (doses optimised but not reported) | |
Outcomes | EDSS, Ashworth scale, symptom reports, unvalidated 4‐point scale of tolerability and 5‐point scale of overall therapeutic effect | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | B ‐ Unclear |